What is ENTXW's health score?

Entera Bio Ltd. (ENTXW) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ENTXW's estimated fair value?

Based on our 5-year discounted cash flow model, Entera Bio Ltd.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ENTXW undervalued or overvalued?

Our model currently rates ENTXW as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ENTXW... Refresh in a moment for the full analysis.

Entera Bio Ltd. (ENTXW)

Healthcare Inconclusive inconclusive mixed

$0.0

Updated: 2026-06-06

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

40 Weak

Relative Value

60 Healthy

Capital Allocation

50 Mixed

Risk

50 Mixed

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Altman Z-Score in distress zone — elevated bankruptcy risk

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.